Aceragen (IDRA) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	244.46M
Short-term investments	178.49M
Prepaid expenses and other current assets
Total current assets	639.88M
Property and equipment, net	152.26M
Restricted cash
Total assets	960.53M
Accounts payable	42.78M
Accrued expenses	71.45M
Total current liabilities	114.23M
Other liabilities
Total liabilities	629.83M
Commitments and contingencies	0
Preferred stock, $0.01 par value, Authorized - 5,000 shares Series A convertible preferred stock, Designated - 1,500 shares, Issued and outstanding - 1 share
Common stock, $0.001 par value, Authorized - 70,000 shares Issued and outstanding - 27,626 and 27,596 shares at June 30, 2011 and December 31, 2010, respectively	802K
Additional paid-in capital
Accumulated deficit	288.18M
Accumulated other comprehensive income	4.16M
Total stockholders' equity	330.7M
Total liabilities and stockholders' equity	960.53M

Entities mentioned with IDRA

View All Entities